Full Text
Canadian Public Reimbursement of Subsequent Entry Biologics (Sebs) / Biosimilars

Abstract

Authors

E.C. Siu G. Wyatt

Back to Volume 18, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×